Latest data updates for mRNA Revolution Tracker.https://watchboard.dev/en-ushttps://watchboard.dev/mrna-revolution/#digest-2026-04-14/https://watchboard.dev/mrna-revolution/#digest-2026-04-14/Comprehensive seed backfill for the mRNA Revolution tracker covering the full platform timeline from the December 2020 COVID vaccine authorizations through 2026. Key milestones documented: FDA/EMA/WHO COVID mRNA vaccine approvals (2020–2022), bivalent booster authorizations, KEYNOTE-942 Phase 2 melanoma data (44% recurrence reduction), FDA Breakthrough Therapy Designation for mRNA-4157/V940, first non-COVID mRNA vaccine approvals (mResvia RSV, 2023), Nobel Prize to Karikó and Weissman, Japan's first saRNA approval (ARCT-154/Kostaive), Phase 3 cancer vaccine program launch, mRNA flu vaccine Phase 3, and advancing HIV/malaria/rare disease programs. Data populated across 6 sections: 8 KPIs, 30 timeline events (5 eras), 20 global map points, 15 contested claims, 12 key actors, and 8 economic indicators.Tue, 14 Apr 2026 00:00:00 GMTseed